Literature DB >> 25308025

Unique morphology of intratubular light chain casts in multiple myeloma: the amyloid cast nephropathy.

Alok Sharma1, Savita Bansal, Ramesh Jain.   

Abstract

Cast nephropathy is the most frequent pattern of renal involvement in multiple myeloma characterized by presence of tubular casts with characteristic morphology that are composed of monotypic (either kappa or lambda) light chains as seen by immunofluorescence microscopy. Rarely these casts may show evidence of amyloidogenesis and assume a unique morphology, which needs to be appreciated for arriving at accurate diagnosis. We present the case of an elderly male presenting with features of acute kidney injury and detected with extensive inspissation of intratubular casts with lambda light chain restriction and a unique morphology with spiculated congophilic periphery. Further investigations confirmed the presence of systemic myeloma. Presence of intratubular amyloid casts is a rare occurrence which needs to be recognized by the pathologist and forms a vital element in timely diagnosis of the systemic disease which often presents with renal involvement.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25308025     DOI: 10.4103/0377-4929.142712

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  3 in total

1.  Unusual morphology of amyloid cast nephropathy in renal biopsy portending poor prognosis.

Authors:  Meyyappa Devan Rajagopal; Rajesh Nachiappa Ganesh; Sreejith Parameswaran; Dhanin Puthiyottil
Journal:  BMJ Case Rep       Date:  2018-12-22

Review 2.  Two kinds of rare light chain cast nephropathy caused by multiple myeloma: case reports and literature review.

Authors:  Li-Jun Sun; Hong-Rui Dong; Xiao-Yi Xu; Guo-Qin Wang; Hong Cheng; Yi-Pu Chen
Journal:  BMC Nephrol       Date:  2021-01-28       Impact factor: 2.388

3.  Oligosecretory Myeloma With Amyloidosis and Alopecia.

Authors:  Anum Bilal; Paul Der Mesropian; Franklin Lam; Gulvahid Shaikh
Journal:  J Investig Med High Impact Case Rep       Date:  2018-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.